Infliximab for the treatment of plaque psoriasis

References

• AhmadKRogersS2006Three years’ experience with infliximab in recalcitrant psoriasisClin Exp Dermatol31630316901301
   PubMed Web of Science ®Google Scholar
• AnkerSDCoatsAJS2002How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACHInt J Cardiol861233012419548
   PubMed Web of Science ®Google Scholar
• BannoTGazelABlumenbergM2004Effects of tumor necrosis factor-alpha in epidermal keratinocytes revealed using global transcriptional profilingJ Biol Chem279326334215145954
   PubMed Web of Science ®Google Scholar
• BehmBWBickstonSJ2007Efficacy of infliximab for luminal and fistulizing Crohn’s disease and in ulcerative colitisCurr Treat Options Gastroenterol10171717547855
   PubMedGoogle Scholar
• Centocor2007Remicade [online]Accessed 26 Nov 2007 www.remicade.com
   Google Scholar
• FDA2006Biologic license application efficacy supplements approved [online]Accessed 15 June 2007 http://www.fda.gov
   Google Scholar
• BongartzTSuttonAJSweetingMJ2006Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trialsJAMA29522758516705109
   PubMed Web of Science ®Google Scholar
• BrownSLGreeneMHGershonSK2002Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug AdministrationArthritis Rheum463151812483718
   PubMed Web of Science ®Google Scholar
• CallenJP2007Complications and adverse reactions in the use of newer biologic agentsSemin Cutan Med Surg2661417349557
   PubMed Web of Science ®Google Scholar
• CassanoNLoconsoleFAmorusoA2004Infliximab monotherapy for refractory psoriasis: preliminary resultsInt J Immunopathol Pharmacol173738015461871
   PubMed Web of Science ®Google Scholar
• ChanJJGebauerK2003Treatment of severe recalcitrant plaque psoriasis with single-dose intravenous tumour necrosis factor-alpha antibody (infliximab)Australas J Dermatol441162012752184
   PubMedGoogle Scholar
• ChaudhariURomanoPMulcahyLD2001Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trialThe Lancet35718427
   PubMed Web of Science ®Google Scholar
• ChongBFWongHK2007Immunobiologics in the treatment of psoriasisClin Immunol1231293817317321
   PubMed Web of Science ®Google Scholar
• ChungESPackerMLoKH2003aRandomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-{alpha}, in patients with moderate-to-severe heart failure: Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) TrialCirculation10731334012796126
   PubMed Web of Science ®Google Scholar
• ChungESPackerMLoKH2003bRandomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trialCirculation10731334012796126
   PubMed Web of Science ®Google Scholar
• CostaMFSaidNRZimmermannB2007Drug-induced lupus due to anti-tumor necrosis factor agentsSemin Arthritis Rheum1029 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• ElderJTNairRPHenselerT2001The genetics of psoriasis 2001: the odyssey continuesArch Dermatol13714475411708947
   PubMed Web of Science ®Google Scholar
• EllerinTRubinRHWeinblattME2003Infections and anti-tumor necrosis factor therapyArthritis Rheum4830132214613261
   PubMed Web of Science ®Google Scholar
• FeldmanAMCombesAWagnerD2000The role of tumor necrosis factor in the pathophysiology of heart failureJ Am Coll Cardiol355374410716453
   PubMed Web of Science ®Google Scholar
• FeldmanSRGordonKBBalaM2005Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trialBr J Dermatol1529546015888152
   PubMed Web of Science ®Google Scholar
• GardamMAKeystoneECMenziesR2003Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical managementLancet Infect Dis31485512614731
   PubMed Web of Science ®Google Scholar
• GelfandJMSternRSNijstenT2005The prevalence of psoriasis in African Americans: results from a population-based studyJ Am Acad Dermatol5223615627076
   PubMed Web of Science ®Google Scholar
• GoedkoopAYKraanMCTeunissenMBM2004Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritisAnn Rheum Dis637697315194570
   PubMed Web of Science ®Google Scholar
• GottliebAB2003Infliximab for psoriasisJ Am Acad Dermatol491127
   PubMed Web of Science ®Google Scholar
• GottliebABChaudhariUMulcahyLD2003Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasisJ Am Acad Dermatol488293512789171
   PubMed Web of Science ®Google Scholar
• GottliebABEvansRLiS2004Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trialJ Am Acad Dermatol515344215389187
   PubMed Web of Science ®Google Scholar
• GottliebABMasudSRamamurthiR2003Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgarisJ Am Acad Dermatol48687512522373
   PubMed Web of Science ®Google Scholar
• HaitzKAKalbRE2007Infliximab in the treatment of psoriasis in patients previously treated with etanerceptJ Am Acad Dermatol57120517482715
   PubMed Web of Science ®Google Scholar
• MedWatch2004Important drug warning [online]Accessed 8 July 2007 URL: http://www.fda.gov
   Google Scholar
• KalbREGurskeJ2005Infliximab for the treatment of psoriasis: clinical experience at the State University of New York at BuffaloJ Am Acad Dermatol536162216198781
   PubMed Web of Science ®Google Scholar
• KaurNMahlT2007Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 casesDig Dis and Sci521481417429728
   PubMed Web of Science ®Google Scholar
• KeaneJGershonSWiseRP2001Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agentN Engl J Med345109810411596589
   PubMed Web of Science ®Google Scholar
• KrathenRABerthelotCNHsuS2006Sustained efficacy and safety of infliximab in psoriasis: a retrospective study of 73 patientsJ Drugs Dermatol5251416573258
   PubMedGoogle Scholar
• KrishnanRSHsuS2004Serum sickness due to infliximab in a patient with psoriasisJ Drugs Dermatol3305815176166
   PubMedGoogle Scholar
• KruegerGKooJLebwohlM2001The impact of psoriasis on quality of life: results of a 1998 national psoriasis foundation patient-membership surveyArch Dermatol137280411255325
   PubMed Web of Science ®Google Scholar
• Kruger-KrasagakisSGalanopoulosVKGiannikakiL2006Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasisBr J Dermatol154460616445776
   PubMed Web of Science ®Google Scholar
• KwonHJCoteTRCuffeMS2003Case Reports of Heart Failure after Therapy with a Tumor Necrosis Factor AntagonistAnn Intern Med1388071112755552
   PubMed Web of Science ®Google Scholar
• LangleyRGGuptaAKChermanAM2007Biologic therapeutics in the treatment of psoriasis. Part 1: reviewJ Cutan Med Surg119912217511926
   PubMed Web of Science ®Google Scholar
• LebwohlM2003PsoriasisThe Lancet3611197204
   PubMed Web of Science ®Google Scholar
• MarkhamMullanGoldenM2006Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapyJournal of the American Academy of Dermatology5410031216713454
   PubMed Web of Science ®Google Scholar
• MarkhamALambHM2000Infliximab: A review of its use in the management of rheumatoid arthritisDrugs5913415910882166
   PubMed Web of Science ®Google Scholar
• MatzingerP2002The danger model: a renewed sense of selfScience296301511951032
   PubMed Web of Science ®Google Scholar
• MenterAFeldmanSRWeinsteinGD2007A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasisJ Am Acad Dermatol5631.e1.e1517097378
   PubMed Web of Science ®Google Scholar
• MohanNEdwardsETCuppsTR2001Demyelination occurring during anti-tumor necrosis factor therapy for inflammatory arthritidesArthritis Rheum442862911762947
   PubMed Web of Science ®Google Scholar
• National Psoriasis Foundation2007About psoriasis: statistics [online]Accessed 14 June 2007 www.psoriasis.org
   Google Scholar
• NickoloffBJ1991The cytokine network in psoriasisArch Dermatol127871842036036
   PubMed Web of Science ®Google Scholar
• NickoloffBJNestleFO2004Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunitiesJ Clin Invest11316647515199399
   PubMed Web of Science ®Google Scholar
• PoulalhonNBegonELebbeC2007A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunityBr J Dermatol1563293617223874
   PubMed Web of Science ®Google Scholar
• Ramos-CasalsMBrito-ZerónPMuñozS2007Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 casesMedicine862425117632266
   PubMed Web of Science ®Google Scholar
• RappSRFeldmanSRExumML1999Psoriasis causes as much disability as other major medical diseasesJ Am Acad Dermatol41401710459113
   PubMed Web of Science ®Google Scholar
• ReichKNestleFOPappK2005Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trialThe Lancet366136774
   PubMed Web of Science ®Google Scholar
• RobinsonWHGenoveseMCMorelandLW2001Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?Arthritis Rheum4419778311592357
   PubMed Web of Science ®Google Scholar
• SauderDNMamelakAJ2004Understanding the new clinical landscape for psoriasis: a comparative review of biologicsJ Cutan Med Surg82051216091996
   PubMed Web of Science ®Google Scholar
• SchellekensH2002Immunogenicity of therapeutic proteins: clinical implications and future prospectsClin Ther2417204012501870
   PubMed Web of Science ®Google Scholar
• SchopfREAustHKnopJ2002Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha, infliximabJ Am Acad Dermatol468869112063486
   PubMed Web of Science ®Google Scholar
• SetoguchiSSolomonDHWeinblattME2006Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritisArthritis Rheum5427576416947774
   PubMed Web of Science ®Google Scholar
• ShearNH2006Fulfilling an unmet need in psoriasis: do biologicals hold the key to improved tolerability?Drug Saf29496616454534
   PubMed Web of Science ®Google Scholar
• SmithCHJacksonKBashirSJ2006Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label studyBr J Dermatol155160916792769
   PubMed Web of Science ®Google Scholar
• SriJCTsaiCLDengA2007Osteomyelitis occurring during infliximab treatment of severe psoriasisJ Drugs Dermatol62071017373180
   PubMedGoogle Scholar
• StraubRHHärlePSarzi-PuttiniP2006Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of antiinflammatory actionArthritis Rheum5420394616802339
   PubMed Web of Science ®Google Scholar
• ten HoveTvan MontfransCPeppelenboschMP2002Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn’s diseaseGut502061111788561
   PubMed Web of Science ®Google Scholar
• Torre-AmioneGKapadiaSLeeJ1996Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heartCirculation93704118640999
   PubMed Web of Science ®Google Scholar
• TurbittMLAkhurstRJWhiteSI1990Localization of elevated transforming growth factor-alpha in psoriatic epidermisJ Investig Dermatol95229322380581
   PubMed Web of Science ®Google Scholar
• WahieSAlexandroffAReynoldsNJ2006Hepatitis: a rare, but important, complication of infliximab therapy for psoriasisClin Exp Dermatol31460116681606
   PubMed Web of Science ®Google Scholar
• WolfeFMichaudK2007Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational studyArthritis Rheum5628869517729297
   PubMed Web of Science ®Google Scholar
• WoolacottNFKhadjesariZCBruceIN2006Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic reviewClin Exp Rheumatol245879317181932
   PubMed Web of Science ®Google Scholar